Anticonvulsant

Apr 20, 2018

UCB's Commitment in Neurology

Apr 20, 2018

UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen

Mar 28, 2018

Biscayne Neurotherapeutics Licenses Chinese Rights To Its Novel Antiepileptic Agent To Global Drug Development Centre (GDCC) China

Oct 19, 2017

Biscayne Neurotherapeutics Reports Successful Phase 1b Clinical Trial Results For Its Novel Antiepileptic Agent